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An understanding of the full powers of brown adipose tissue (BAT) is only successively being accumulated. In
a paper inNatureMedicine, Bartelt et al. (2011) add further impressive aspects to the potential powers of BAT
in the combat against the metabolic syndrome by demonstrating its vast capacity for triglyceride clearance
and glucose disposal.Until very recently, brown adipose tissue
(BAT) seemed to attract interest from
only a few hibernation researchers and
mitochondrial bioenergeticists. This was
understandable. BAT is not easily discern-
able: It has a color and texture that blends
into both fat and muscle, and it is found in
small depots spread out in different parts
of the body, totally amounting to only
a small percentage of total body weight
(Figure 1A). Yet this organ has the power
to be a main player in metabolism. In their
recent study in Nature Medicine, Bartelt
et al. (2011) reveal new major roles for
BAT in blood triglyceride clearance and
glucose disposal.
To generate heat for thermogenesis,
BAT first uses its stored lipid as substrate
(Figure 1B). This early phase of thermo-
genesis corresponds molecularly to
norepinephrine released from the sympa-
thetic nerves activating the release of free
fatty acids from triglyceride droplets
(Figure 1B). Some of these fatty acids
activate UCP1 (uncoupling protein 1).
The remaining fatty acids are imported
into the mitochondria and combusted,
releasing energy as heat, due to UCP1
action. However, with brown fat
comprising such a small percent of total
body weight, the stored lipid can sustain
thermogenesis for only a short time, andfurther energy supplies must come from
outside the tissue.
The study of Bartelt et al. (2011) reveals
the ability of BAT to import and combust
triglycerides from the circulation and
demonstrates how this uptake delivers
substrate for continued thermogenesis.
By exposing mice to cold, Bartelt et al.
optimized the acute activity of BAT, and
this had dramatic effects on triglyceride
levels in the blood. Specifically, plasma
triglycerides (mainly in the form of chylo-
microns, i.e., the dietary fat) practically
disappeared from the circulation—not
because fewer chylomicrons were
formed, but because they were nearly all
cleared by BAT; in fact, nearly half of the
triglyceride from a meal ended up in BAT
(Figure 1C). The clearance capacity of
BAT could probably be even higher: prior
to being exposed to cold, the mice had
been living at normal environmental
temperature and would thus have to also
shiver in the cold (explaining the fatty
acid uptake in the muscles). Had cold-
acclimated mice with recruited BAT
been used, the fraction entering BAT
may have been even higher.
The data of Bartelt et al. lead to the
following scenario for the high triglyceride
clearance into BAT (Figure 1D). While
norepinephrine activates the release offree fatty acids from triglyceride droplets
within the brown fat cell, it also induces
VEGF (Fredriksson et al., 2005) and lipo-
protein lipase (LPL) gene expression
(Mitchell et al., 1992; Bartelt et al., 2011).
VEGF leads to increased capillary perme-
ability, allowing plasma triglycerides to
leave the capillaries (as elegantly video-
recorded in vivo by Bartelt et al.). LPL
degrades the triglycerides and allows
fatty acids to become available for
combustion in the tissue through the
action of the plasma membrane trans-
porter CD36; without CD36, the mice
could not fight the cold.
In addition to BAT being a major lipid-
combusting tissue, Bartelt et al. also point
to BAT as being a major organ for glucose
disposal, as (particularly in obese mice)
a large fraction of ingested glucose is
channeled to BAT (Figure 1E), where the
glucose, just like lipids, will be com-
busted. This result reinforces the obser-
vation that BAT is an avid glucose uptake
organ (Cawthorne, 1989). Indeed, the
present realization that adult humans
possess active BAT initially arose from
the unexpected observations, made by
radiologists using glucose uptake to
search for tumors, of highly active glucose
uptake into areas that turned out to be
BAT (Hany et al., 2002). Most of the high
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Figure 1. The Powers of Brown Adipose Tissue
(A) Relative amounts of different tissues in the mouse, based on data from Bartelt et al. (2011) for normal
(‘‘lean’’) mice.
(B) The initial ignition of BAT thermogenic activity. Norepinephrine (NE) released from nerves stimulates the
release of free fatty acids (FFA) from triglyceride (TG) droplets; some FFA activate uncoupling protein 1
(UCP1), and most are combusted in the mitochondria (brown box).
(C) The proportions of ingested triglycerides that are taken up into different tissues, based on data from
Bartelt et al. (2011) from gavage feeding.
(D) The pathway for triglyceride clearance into BAT. NE activates the expression in the nucleus (blue circle)
of the genes for vascular endothelial growth factor (VEGF) (that may increase capillary permeability) and
lipoprotein lipase (LPL) that release FFA from the triglyceride-rich lipoproteins (TRL); the uptake is facili-
tated by CD36 (also known as FAT).
(E) The proportions of ingested glucose that are taken up into different tissues, based on data from Bartelt
et al. (2011) from obese animals in the cold.
(F) The pathways for glucose disposal by BAT. NE both stimulates the expression of the glucose trans-
porter 1 and 4 (GLUT1/4) genes and activates/translocates these transporters; glucose is taken up and
converted to pyruvate (pyr) that is oxidized in the mitochondria.
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Previewsglucose uptake in BAT is probably due to
the intense combustion of glucose (in the
form of pyruvate) in the mitochondria,
rather than being due to insulin action.
Brown fat mitochondria are avid combus-
tors of pyruvate, as long as UCP1 is kept
active by free fatty acids (Shabalina
et al., 2004). Glucose transporters, specif-
ically GLUT1 and GLUT4, may also be
directly involved in the stimulated uptake,
since their activity and expression are
increased by both cold and norepineph-
rine (Nikami et al., 1992; Dallner et al.,
2006; Bartelt et al., 2011). Glucose that
is not immediately combusted may accu-
mulate as glycogen (Glick et al., 1983) and
ultimately be converted to lipids to
replenish the triglyceride droplets. This
high BAT capacity for both triglyceride
clearance and glucose disposal allows
a mouse exposed to cold to eat 3–4 times
that of a mouse at thermoneutrality
without becoming obese.
Decreasing plasma lipids, lowering
plasma glucose, and diminishing obesity:
It is clear that the studies of Bartelt et al.
point to BAT as having a potential for
reducing or eliminating the risk factors
for the metabolic syndrome, for obesity,
and for obesity-related comorbidities,
including type II diabetes (i.e., if insulin
resistance is considered to be [partly]
due to chronic high insulin levels counter-
acting high plasma glucose, the high
capacity of BAT for glucose disposal
would directly oppose this undesired
development). It may rightly be argued
that the results of Bartelt et al. overesti-
mate what BAT actually does in adult
man: mice living at normal animal house
temperatures are actually under constant
cold stress and therefore have more BAT
than mice at thermoneutrality (30C),
a condition that better resembles ours.
However, the metabolic powers of BAT
are still visible even in such thermoneutral
mice (Feldmann et al., 2009). This implies
that those adults who can maintain BAT
in an active state into late adulthood may
use its powers to combat the metabolic
syndrome. The study of Bartelt et al. will
therefore enhance the quest to augment
the capacity and activity of BAT in humans
and to keep it active during adulthood.REFERENCES
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